Clinical Safety and Efficacy of Kanglaite® (Coix Seed Oil) Injection Combined with Chemotherapy in Treating Patients with Gastric Cancer |
Zhan, Yi-Ping
(Department of Chemotherapy, Jiangsu Cancer Hospital & Research Institute)
Huang, Xin-En (Department of Chemotherapy, Jiangsu Cancer Hospital & Research Institute) Cao, Jie (Department of Chemotherapy, Jiangsu Cancer Hospital & Research Institute) Lu, Yan-Yan (Department of Chemotherapy, Jiangsu Cancer Hospital & Research Institute) Wu, Xue-Yan (Department of Chemotherapy, Jiangsu Cancer Hospital & Research Institute) Liu, Jin (Department of Chemotherapy, Jiangsu Cancer Hospital & Research Institute) Xu, Xia (Department of Chemotherapy, Jiangsu Cancer Hospital & Research Institute) Xiang, Jin (Department of Research, Jiangsu Cancer Hospital & Research Institute) Ye, Li-Hong (Nanjing University of Traditional Chinese Medicine) |
1 | Clancey JK (1995). Karnofsky performance scale. J Neurosci Nurs, 27, 220. |
2 | Eisenhauer EA, Therasse P, Bogaerts J, et al (2009). New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 45, 228-47. DOI ScienceOn |
3 | Friendlander AH, Ettinger RL (2009). Karnofsky performance status scale. Spec Care Dentist, 29, 147-8. DOI |
4 | Gao LL, Huang XE, Zhang Q, et al (2011). A Cisplatin and vinorelbine (NP) regimen as a postoperative adjuvant chemotherapy for completely resected breast cancers in China: final results of a phase II clinical trial. Asian Pac J Cancer Prev, 12, 77-80. |
5 | Gong P, Huang XE, Chen CY, et al (2012). Comparison on complications of peripherally inserted central catheters by ultrasound guide or conventional method in cancer patients. Asian Pac J Cancer Prev, 13, 1873-5. DOI |
6 | Huang XE, Li CG, Li Y, et al (2011). Weekly TP regimen as a postoperative adjuvant chemotherapy for completely resected breast cancer in China: final result of a phase II trial. Asian Pac J Cancer Prev, 12, 2797-800. |
7 | Jiang Y, Huang XE, Yan PW, et al (2010). Validation of treatment efficacy of a computer-assisted program for breast cancer patients receiving postoperative adjuvant chemotherapy. Asian Pac J Cancer Prev, 11, 1059-62. |
8 | Kaba H, Fukuda H, Yamamoto S, Ohashi Y (2004). [Reliability at the National Cancer Institute-Common Toxicity Criteria version 2.0]. Gan To Kagaku Ryoho, 31, 1187-92. |
9 | Lian Z, Lu Y, Hou E, Wang X (2006). [Combination of GP regimen and Kanglaite in the treatment of advanced nonsmall cell lung cancer]. Zhongguo Fei Ai Za Zhi, 9, 74-7. |
10 | Li CG, Huang XE, Li Y, et al (2011). Clinical observations on safety and efficacy of administered by rectal route in treating cancer related pain. Asian Pac J Cancer Prev, 12, 2477-8. |
11 | Li CG, Huang XE, Li Y (2011). Phase II trial of irinotecan plus nedaplatin (INP) in treating patients with extensive stage small cell lung cancer. Asian Pac J Cancer Prev, 12, 487-90. |
12 | Li Y, Yan PW, Huang XE, et al (2011). MDR1 gene C3435T polymorphism is associated with clinical outcomes in gastric cancer patients treated with postoperative adjuvant chemotherapy. Asian Pac J Cancer Prev, 12, 2405-9. |
13 | Li CG, Huang XE, Xu L, et al (2012). Clinical application of serum tumor associated material (TAM) from non-small cell lung cancer patients. Asian Pac J Cancer Prev, 13, 301-4. 과학기술학회마을 DOI |
14 | Li D (2005). [The anticancer drug Kang-Lai-Te emulsion for infusion]. Vestn Ross Akad Med Nauk, 9, 32-7. |
15 | Liu W, Li SY, Huang XE, et al (2012). Inhibition of tumor growth in vitro by a combination of extracts from rosa roxburghii tratt and fagopyrum cymosum. Asian Pac J Cancer Prev, 13, 2409-14. 과학기술학회마을 DOI |
16 | Shu J, Li CG, Liu YC, et al (2012). Comparison of serum tumor associated material (TAM) with conventional biomarkers in cancer patients. Asian Pac J Cancer Prev, 13, 2399-403. 과학기술학회마을 DOI |
17 | Xu HX, Huang XE, Li Y, et al (2011). A clinical study on safety and efficacy of Aidi injection combined with chemotherapy. Asian Pac J Cancer Prev, 12, 2233-6. |
18 | Xu HX, Huang XE, Qian ZY, et al (2011). Clinical observation of combined with chemotherapy in advanced colorectal cancer patients. Asian Pac J Cancer Prev, 12, 3087-90. |
19 | Xu JW, Li CG, Huang XE, et al (2011). Ubenimex capsule improves general performance and chemotherapy related toxicity in advanced gastric cancer cases. Asian Pac J Cancer Prev, 12, 985-7. |
20 | Xu T, Xu ZC, Zou Q, Yu B, Huang XE (2012). P53 Arg72Pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in Asians but not Caucasians. Asian Pac J Cancer Prev, 13, 2349-54. 과학기술학회마을 DOI |
21 | Yan PW, Huang XE, Jiang Y, et al (2010). Clinical comparison of safety and efficacy of vinorelbine/epirubicin (NE) with fluorouracil/epirubicin/cyclophosphamide (FEC). Asian Pac J Cancer Prev, 11, 1115-8. |
22 | Yan PW, Huang XE, Yan F, et al (2011). Influence of MDR1 gene codon 3435 polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancer. Asian Pac J Cancer Prev, 12, 2291-4. |
23 | Yao CY, Huang XE, Tang JH, et al (2010). Clinical observationson safety of fixed dose rate gemcitabine chemotherapy by intravenous infusion. Asian Pac J Cancer Prev, 11, 553-5. |
24 | Yu DS, Huang XE, Zhou JN, et al (2012). A Comparative Study on the Value of Anal Preserving Surgery for Aged People with Low Rectal Carcinoma in Jiangsu, China. Asian Pac J Cancer Prev, 13, 2339-40. 과학기술학회마을 DOI |
25 | Zhang LQ, Huang XE, Wang J (2011). The cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a metaanalysis of 20 populations. Asian Pac J Cancer Prev, 12, 81-5. |
26 | Zhang XZ, Huang XE, Xu YL, et al (2012). APhase II study on voriconazole for treatment of Chinese patients with malignant hematological disorders and invasive aspergillosis. Asian Pac J Cancer Prev, 13, 2415-8. DOI |
27 | Zhou JN, Huang XE, Ye Z, et al (2009). Weekly paclitaxel/Docetaxel combined with a paltinum in the treatment of advanced non-samll cell lung cancer: a study on efficacy, safety and pre-medication. Asian Pac J Cancer Prev, 10, 1147-50. |
28 | Zhu L, Yang Z, Wang S, Tang Y (2009). [Kanglaite for Treating Advanced Non-small-cell Lung Cancer: A Systematic Review.]. Zhongguo Fei Ai Za Zhi, 12, 208-15. |